TY  - JOUR
JF  - Advances in Health Sciences Research
A1  - Supandi Supandi, Supandi
PB  - Atlantis Press
N2  - Kaempferia galanga has anti-inflammatory activity and worth developing as lipoxygenase inhibitors. The aim of this study was to determined ?-3-carene, one of the potential compounds of K. galanga, as a lipoxygenase inhibitor. The LOX-inhibitor activity was tested in-vitro. The result showed that the IC50 of ?-3-carene was 23.10 ?M, which was less potential compare to zileuton (7.54 ?M). The study showed that K. galanga contains possible active components that could be developed as 5-LOX-inhibitor.
TI  - In Vitro Study of Kaempferia galanga L. Compound, ?- 3-Carene, Against 5-Lipoxygenase
ID  - repository6140
SP  - 443
EP  - 444
UR  - http://repository.uhamka.ac.id/id/eprint/6140/
AV  - public
VL  - 33
ER  -